Norio Yamamoto

9.2k citations

341 papers · 6.6k indexed · h-index 42

Pulmonary and Respiratory Medicine top 0.5%
Surgery top 2%
Oncology top 2%
Biotechnology top 0.1%
Biomedical Engineering top 2%

Co-authors: Hiroyuki Tsuchiya Katsuhiro Hayashi Katsuro Tomita Robert M. Hoffman Akihiko Takeuchi Shinji Miwa Kentaro Igarashi Kensuke Yamauchi
Topics: Sarcoma Diagnosis and Treatment (134 papers)Cancer Research and Treatments (78 papers)Bone Tumor Diagnosis and Treatments (73 papers)
Cited by: Biotechnology Pulmonary and Respiratory Medicine Rheumatology
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaThe Journal of Immunology
Partner nations: Japan United States China

In The Last Decade

Norio Yamamoto

326 papers receiving 6.5k citations

Peers

Countries citing papers authored by Norio Yamamoto

Since Specialization

Citations

This map shows the geographic impact of Norio Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norio Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norio Yamamoto more than expected).

Fields of papers citing papers by Norio Yamamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norio Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norio Yamamoto. The network helps show where Norio Yamamoto may publish in the future.

Co-authorship network of co-authors of Norio Yamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Norio Yamamoto. A scholar is included among the top collaborators of Norio Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norio Yamamoto. Norio Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel predictors of immune checkpoint inhibitor response and prognosis in advanced non‐small‐cell lung cancer with bone metastasis 2023 ·Cancer Medicine ·Yohei Asano,Norio Yamamoto,Satoru Demura,Katsuhiro Hayashi,Akihiko Takeuchi,Satoshi Kato,Shinji Miwa,Kentaro Igarashi,Takashi Higuchi,Yuta Taniguchi,Sei Morinaga,Takashi Sone,Miho Okuda,Isao Matsumoto,Seiji Yano,Hiroyuki Tsuchiya	13
2	Graft Survivals after Reconstruction Using Tumor-Bearing Frozen Bone in the Extremities 2023 ·Cancers ·Shinji Miwa,Norio Yamamoto,Katsuhiro Hayashi,Akihiko Takeuchi,Kentaro Igarashi,(unknown),Yuta Taniguchi,Sei Morinaga,Yohei Asano,Hiroyuki Tsuchiya	2
3	Needle tract seeding of a sclerosing epithelioid fibrosarcoma in a biopsy tract: a case report 2023 ·BMC Musculoskeletal Disorders ·(unknown),Shinji Miwa,Norio Yamamoto,Katsuhiro Hayashi,Akihiko Takeuchi,Kentaro Igarashi,Yuta Taniguchi,Yoshihiro Araki,Hirotaka Yonezawa,Takayuki Nojima,Hiroyuki Tsuchiya	0
4	A scoring system combining clinical, radiological, and histopathological examinations for differential diagnosis between lipoma and atypical lipomatous tumor/well-differentiated liposarcoma 2022 ·Scientific Reports ·Yohei Asano,Shinji Miwa,Norio Yamamoto,Katsuhiro Hayashi,Akihiko Takeuchi,Kentaro Igarashi,Hirotaka Yonezawa,Yoshihiro Araki,Sei Morinaga,Takayuki Nojima,Hiroko Ikeda,Hiroyuki Tsuchiya	18
5	Joint-preservation surgery for bone sarcoma in adolescents and young adults 2022 ·International Journal of Clinical Oncology ·Norio Yamamoto,Yoshihiro Araki,Hiroyuki Tsuchiya	7
6	A Viability Analysis of Tumor-Bearing Frozen Autograft for the Reconstruction After Resection of Malignant Bone Tumors Using 99mTc-MDP Scintigraphy 2022 ·Clinical Nuclear Medicine ·Yoshihiro Araki,Norio Yamamoto,Katsuhiro Hayashi,Akihiko Takeuchi,Shinji Miwa,Kentaro Igarashi,Takashi Higuchi,Kensaku Abe,Yuta Taniguchi,Hirotaka Yonezawa,Sei Morinaga,Yohei Asano,Takayuki Nojima,Junichi Taki,Hiroyuki Tsuchiya	1
7	Family cancer history and smoking habit associated with sarcoma in a Japanese population study 2022 ·Scientific Reports ·Yoshihiro Araki,Norio Yamamoto,(unknown),Takahiro Higashi,Aya Kuchiba,Katsuhiro Hayashi,Akihiko Takeuchi,Shinji Miwa,Kentaro Igarashi,Makoto Endo,Eisuke Kobayashi,Hiroyuki Tsuchiya,Akira Kawai	4
8	Surgical Site Infection after Bone Tumor Surgery: Risk Factors and New Preventive Techniques 2022 ·Cancers ·Shinji Miwa,Norio Yamamoto,Katsuhiro Hayashi,Akihiko Takeuchi,Kentaro Igarashi,Hiroyuki Tsuchiya	16
9	Primary Osteosarcoma in Patients Over 75 Years of Age: A Case Series and Literature Review 2022 ·In Vivo ·Yoshihiro Araki,Norio Yamamoto,Katsuhiro Hayashi,Akihiko Takeuchi,Shinji Miwa,Kentaro Igarashi,Takashi Higuchi,Kensaku Abe,Yuta Taniguchi,Hirotaka Yonezawa,Sei Morinaga,Yohei Asano,Takayuki Nojima,Hiroyuki Tsuchiya	4
10	The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma 2021 ·Scientific Reports ·Yoshihiro Araki,Norio Yamamoto,Katsuhiro Hayashi,Akihiko Takeuchi,Shinji Miwa,Kentaro Igarashi,Takashi Higuchi,Kensaku Abe,Yuta Taniguchi,Hirotaka Yonezawa,Sei Morinaga,Yohei Asano,Hiroko Ikeda,Takayuki Nojima,Hiroyuki Tsuchiya	10
11	Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma 2021 ·Scientific Reports ·Yoshihiro Araki,Norio Yamamoto,Katsuhiro Hayashi,Akihiko Takeuchi,Shinji Miwa,Kentaro Igarashi,Takashi Higuchi,Kensaku Abe,Yuta Taniguchi,Hirotaka Yonezawa,Sei Morinaga,Yohei Asano,Hiroko Ikeda,Takayuki Nojima,Hiroyuki Tsuchiya	1
12	Undifferentiated Pleomorphic Sarcoma Arising in a Fibrous Dysplasia Confirmed by GNAS Mutation Analysis 2020 ·JBJS Case Connector ·Miho Okuda,Satoshi Kobayashi,Toshifumi Gabata,Norio Yamamoto,Takayuki Nojima	0
13	Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse model 2019 ·Biochemical and Biophysical Research Communications ·Takashi Higuchi,Kentaro Miyake,Hiromichi Oshiro,Norihiko Sugisawa,Norio Yamamoto,Katsuhiro Hayashi,Hiroaki Kimura,Shinji Miwa,Kentaro Igarashi,Sant P. Chawla,Michael Bouvet,Shree Ram Singh,Hiroyuki Tsuchiya,Robert M. Hoffman	35
14	Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse model 2019 ·Biochemical and Biophysical Research Communications ·Takashi Higuchi,Qinghong Han,Kentaro Miyake,Hiromichi Oshiro,Norihiko Sugisawa,Yuying Tan,Norio Yamamoto,Katsuhiro Hayashi,Hiroaki Kimura,Shinji Miwa,Kentaro Igarashi,Michael Bouvet,Shree Ram Singh,Hiroyuki Tsuchiya,Robert M. Hoffman	26
15	Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models 2018 ·Biochemical and Biophysical Research Communications ·Kentaro Igarashi,Kei Kawaguchi,Tasuku Kiyuna,Kentaro Miyake,Masuyo Miyake,Arun S. Singh,Mark A. Eckardt,Scott D. Nelson,Tara A. Russell,Sarah Dry,Yunfeng Li,Norio Yamamoto,Katsuhiro Hayashi,Hiroaki Kimura,Shinji Miwa,Hiroyuki Tsuchiya,Shree Ram Singh,Fritz C. Eilber,Robert M. Hoffman	26
16	Phase I expansion cohort of TAS-115, a novel oral MET/VEGFR/FMS inhibitor, for castration-resistant prostate cancer patients (CRPC pts) with bone metastases 2017 ·Annals of Oncology ·Nobuaki Matsubara,Yoichi Naito,(unknown),Norio Yamamoto,Shunji Takahashi,Hiroji Uemura,Toshihiko Doi	1
17	Synovial sarcoma in knee joint, mimicking low-grade sarcoma confirmed by molecular detection of SYT gene split. 2014 ·PubMed ·Hiroaki Kimura,Norio Yamamoto,Hideji Nishida,Katsuhiro Hayashi,Akihiko Takeuchi,Takayuki Nojima,Hiroko Ikeda,Seiko Sawada‐Kitamura,Hiroyuki Tsuchiya	5
18	Clinical Observations of Caffeine-Potentiated Chemotherapy 2011 ·Norio Yamamoto,Hiroyuki Tsuchiya	5
19	Real-time Imaging of Tumor-Cell Shedding and Trafficking in Lymphatic Channels 2007 ·Cancer Research ·Katsuhiro Hayashi,Ping Jiang,Kensuke Yamauchi,Norio Yamamoto,Hiroyuki Tsuchiya,Katsuro Tomita,A. R. Moossa,Michael Bouvet,Robert M. Hoffman	107
20	Development of Real-time Subcellular Dynamic Multicolor Imaging of Cancer-Cell Trafficking in Live Mice with a Variable-Magnification Whole-Mouse Imaging System 2006 ·Cancer Research ·Kensuke Yamauchi,Meng Yang,Ping Jiang,Mingxu Xu,Norio Yamamoto,Hiroyuki Tsuchiya,Katsuro Tomita,Abdool R. Moossa,Michael Bouvet,Robert M. Hoffman	219

About Norio Yamamoto

Norio Yamamoto is a scholar working on Biotechnology, Rheumatology and Pulmonary and Respiratory Medicine, having authored 341 papers that have together received 6.6k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (134 papers), Cancer Research and Treatments (78 papers) and Bone Tumor Diagnosis and Treatments (73 papers). The work is most often cited by research in Biotechnology (1.5k citations), Pulmonary and Respiratory Medicine (2.4k citations) and Rheumatology (1.1k citations). Norio Yamamoto has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Hiroyuki Tsuchiya, Katsuhiro Hayashi, Katsuro Tomita, Robert M. Hoffman, Akihiko Takeuchi, Shinji Miwa, Kentaro Igarashi, Kensuke Yamauchi, Michael Bouvet and Toshiharu Shirai. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact